Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.
The experts
Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil
Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany
Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.